Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Intas Pharmaceuticals Limited
FDA Inspection
•Intas Pharmaceuticals Limited•May 12, 2023

Intas Pharmaceuticals Limited – FDA Inspection, May 12, 2023

Record Details

This FDA Inspection record concerns Intas Pharmaceuticals Limited, with an inspection on May 12, 2023, issued by the Office of Inspections and Investigations.

Company
Intas Pharmaceuticals Limited
Inspection Date
May 12, 2023
Office
Office of Inspections and Investigations
People
  • Arsen Karapetyan
  • Justin A. Boyd (Investigator)
  • Rita K. Vick (Issuing Officer)
View Company Profile

ID · cc06d269-7eb7-476e-8b4c-d7dbea9b39ff

Inspection Facts

Inspection number
1206170
FDA center
Human Drugs
Outcome
Form 483 issued

FDA Citations

16
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.113(a)Procedures for non-sterile drug products
  3. 21 CFR 211.113(b)Validation lacking for sterile drug products
  4. 21 CFR 211.165(e)Test methods
  5. 21 CFR 211.180(e)(1)Representative Number of Batches for Annual Review
  6. 21 CFR 211.188Prepared for each batch, include complete information
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.194(a)Complete test data included in records
  9. 21 CFR 211.22(d)Procedures not in writing, fully followed
  10. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System

Showing 10 of 16 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Intas Pharmaceuticals Limited

14
DateClassificationOfficeProject area
July 12, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
August 2, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 14, 2018VAICenter for Drug Evaluation and ResearchGeneric Drug Evaluation
August 17, 2018Not classifiedOffice of Inspections and Investigations
June 8, 2018VAICenter for Veterinary MedicinePre-Approval Eval. of Animal Drugs and Food Additives
View all 14 other inspections on the company page
Other documents for Intas Pharmaceuticals Limited
  • FDA Inspection 1245599 - 2024-07-12
  • FDA Inspection 1098380 - 2019-08-02
  • FDA Inspection 1074349 - 2018-12-14
  • FDA Inspection 1067525 - 2018-08-17
  • FDA Inspection 1056170 - 2018-06-08

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Intas Pharmaceuticals Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.